Relapsed Refractory Peripheral T Cell Lymphoma clinical trials

Explore recruiting relapsed refractory peripheral t cell lymphoma clinical trials.

Recruiting relapsed refractory peripheral t cell lymphoma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Relapsed Refractory Peripheral T Cell Lymphoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Single-Arm, Phase 2 Study of Valemetostat Tosylate Monotherapy in Subjects with Relapsed/Refractory Peripheral T-Cell Lymphoma

Italy, France, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 1-2, Open-Label Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Activity of Tolinapant in Combination with Oral Decitabine/Cedazuridine and Oral Decitabine/Cedazuridine Alone in Subjects with Relapsed/Refractory Peripheral T-cell Lymphoma

France, Spain, Italy, Hungary, Poland

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Relapsed Refractory Peripheral T Cell Lymphoma trials by city

Relapsed Refractory Peripheral T Cell Lymphoma in Toronto Relapsed Refractory Peripheral T Cell Lymphoma in Vancouver Relapsed Refractory Peripheral T Cell Lymphoma in Montreal Relapsed Refractory Peripheral T Cell Lymphoma in Calgary Relapsed Refractory Peripheral T Cell Lymphoma in Edmonton Relapsed Refractory Peripheral T Cell Lymphoma in Ottawa Relapsed Refractory Peripheral T Cell Lymphoma in Winnipeg Relapsed Refractory Peripheral T Cell Lymphoma in Quebec City Relapsed Refractory Peripheral T Cell Lymphoma in Hamilton Relapsed Refractory Peripheral T Cell Lymphoma in Kitchener Relapsed Refractory Peripheral T Cell Lymphoma in London Relapsed Refractory Peripheral T Cell Lymphoma in Halifax Relapsed Refractory Peripheral T Cell Lymphoma in New York Relapsed Refractory Peripheral T Cell Lymphoma in Los Angeles Relapsed Refractory Peripheral T Cell Lymphoma in Chicago Relapsed Refractory Peripheral T Cell Lymphoma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease